Editorials |
From the Department of Physiology, University of Wisconsin School of Medicine and Public Health, Madison.
Correspondence to Dr Richard L. Moss, Department of Physiology, University of Wisconsin Medical School, 1300 University Ave, Madison, WI 53706. E-mail rlmoss{at}physiology.wisc.edu
See related article, pages 323331
Key Words: myosin light chain 2 thick filament development
| Introduction |
|---|
|
|
|---|
Cardiac isoforms of myosin II comprise the motor of myocardial contraction and like all members of this family are composed of 6 subunits6: 2 myosin heavy chains of &200 kDa molecular weight, 2 so-called essential light chains (or light chain 1) of &17 kDa, and 2 regulatory light chains (or light chain 2) of >20 kDa. Subfragment 1 of the heavy chain (Figure) comprises the business end of the motor, containing both the nucleotide and actin-binding sites, whereas the light chains wrap around the rod-like extension of subfragment 1 and are believed to function (minimally) as mechanical stabilizers of this part of myosin during force generation and mechanical work performance. This motor is impressive for its efficiency and its reliability and just as much for the dramatic phenotypic consequences of mutations in its various domains, as in human hypertrophic cardiomyopathies.7
|
| MLC-2 Tunes Myocardial Contraction |
|---|
|
|
|---|
(faster) and ß (slower) myosin heavy chain isoforms expressed in the heart and also species-specific differences in turnover kinetics of these isoforms.6 But tuning of the motor also takes place on a beat-to-beat basis, principally through phosphorylation of MLC-2 or of thick and thin filament accessory proteins as a means to optimize work capacity and energetic efficiency. Work capacity can be varied by regulating the number of cross-bridges binding to actin by controlling the amount of Ca2+ delivered to myoplasm or by controlling myosin turnover kinetics. The rate of myocardial force development increases when [Ca2+] is increased,9 but this does not appear to be caused by acceleration of cross-bridge cycling kinetics, which are invariant with level of activation. Rather, activation dependence of contraction kinetics appears to be a consequence of cooperative binding of cross-bridges to the thin filament.10 At low [Ca2+], thin filaments are partially activated by the binding of Ca2+ to troponin, but once cross-bridges bind, the activation state is enhanced and additional cross-bridges bind. This positive cooperation in cross-bridge binding increases the force at a given [Ca2+] but also slows the rate of force development because of the time taken to recruit additional cross-bridges. Phosphorylation of MLC-2 by myosin light chain kinase11 increases force and accelerates the rate of force development in myocardium12 but slows relaxation13; however, in this case also, the effects on mechanical properties appear to be mediated by changes in the cooperation of cross-bridge binding to actin. Electron microscopy studies have shown that phosphorylation of MLC-2 in isolated thin filaments results in displacement of cross-bridges away from the thick filament, presumably because of electrostatic repulsion between the phosphate group and fixed charge on the surface of the filament.14 In the intact myofilament, MLC-2 phosphorylation would therefore displace cross-bridges to positions closer to actin and thereby increase the likelihood of binding. Such effects are limited to submaximal Ca2+ concentrations,13 suggesting the net effect of the displacement is to speed the cooperative recruitment of cross-bridges to force generating states, which would increase force and the rate of force development. Likewise, slowed rates of relaxation would be a consequence of increased likelihood of cross-bridge re-binding to actin once detached and not a slower rate of detachment.
Epstein and Davis4,5,8 have proposed that transmural variations in regulatory light chain phosphorylation contribute to both diastolic and systolic function in the heart. Their finding in rat heart that the outer (epicardial) layers of myocardium are phosphorylated to a greater degree than the innermost layers suggests that there is a transmural gradient in force production, which is greatest in the epicardium. With respect to ejection, they propose that the rightward torsional twist of the heart (when viewed from the base) during systole would result in stretch of endocardium, which in turn would result in a stretch activation of the endocardium. Such a mechanism could be critical to the later stages of ejection, and since the properties of stretch activation vary with [Ca2+],15 this could also be a mechanism for kinetic tuning of the ejection phase.
| MLC-2 Required for Cardiac Myofibrillogenesis |
|---|
|
|
|---|
| Interesting Possibilities |
|---|
|
|
|---|
Similar Outcomes Caused by Mutations/Deletions of Other Myofibrillar Proteins
Although the mechanism by which deletion of MLC-2 disrupts thick filament assembly and myofibrillogenesis is not known, important clues could emerge from findings that other myofibrillar proteins are important in the process. As Rottbauer et al3 point out, zebrafish lacking titin20 display abnormalities similar to deletion of MLC-2, and mice lacking the atrial isoform of MLC-2 exhibit disruption of myofibrillar organization in the atria.21
Previous work has also shown that phosphorylation of MLC-2 is important in development, as inhibition of myosin light chain kinase disrupts thick filament assembly in embryonic myocytes in culture.19 Thus, when Ca2+ increases during development, myosin light-chain kinase is activated and MLC-2 is phosphorylated and contributes critically to thick filament assembly.19,22
Thus, Rottbauer et al have shown that MLC-2 plays an essential role in the assembly of cardiac thick filament and the sarcomere, but whether this is because of a structural or contractile effect of MLC-2 is presently unknown. Either way, MLC-2 is emerging as an important element in the constellation of factors that affect cardiac function in health and disease.
| Acknowledgments |
|---|
The authors acknowledge NIH grant number HL 82900.
Disclosures
None.
| Footnotes |
|---|
| References |
|---|
|
|
|---|
2. Walker JW. Protein kinase C, troponin I and heart failure: overexpressed, hyperphosphorylated and underappreciated? J Mol Cell Cardiol. 2006; 40: 446450.[CrossRef][Medline] [Order article via Infotrieve]
3. Rottbauer W, Wessels G, Dahme T, Just S, Trano N, Hassel D, Burns CG, Katus HA, Fishman MC. Cardiac myosin light chain-2: a novel essential component of thick-myofilament assembly and contractility of the heart. Circ Res. 2006; 99: 323331.
4. Poetter K, Jiang H, Hassanzedah S, Master SR, Chang A, Dalakas MC, Rayment I, Sellers JR, Fananapazir L, Epstein ND. Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nature Genetics. 1996; 13: 6369.[CrossRef][Medline] [Order article via Infotrieve]
5. Davis JA, Hassanzadeh S, Winitsky S, Lin H, Satorius C, Vemuri R, Aletras AH, Wen H, Epstein ND. The overall pattern of cardiac contraction depends on a spatial gradient of myosin regulatory light chain phosphorylation. Cell. 2001; 107: 631641.[CrossRef][Medline] [Order article via Infotrieve]
6. Schiaffino S, Reggiani C. Molecular diversity of myofibrillar proteins: gene regulation and functional significance. Physiol Rev. 1996; 76: 371423.
7. Seidman JG, Seidman C. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell. 2001; 104: 557567.[CrossRef][Medline] [Order article via Infotrieve]
8. Epstein ND, Davis JS. When is a fly in the ointment a solution and not a problem? Circ Res. 2006; 98: 12121218.
9. Moss RL, Razumova M, Fitzsimons DP. Myosin crossbridge activation of cardiac thin filaments: implications for myocardial function in health and disease. Circ Res. 2004; 94: 12901300.
10. Campbell K. Rate constant of muscle force redevelopment reflects cooperative activation as well as cross-bridge kinetics. Biophy J. 1997; 72: 254262.[Medline] [Order article via Infotrieve]
11. Soderling TR, Stull JT. Structure and regulation of calcium/calmodulin-dependent protein kinases. Chem Rev. 2001; 101: 23412352.[CrossRef][Medline] [Order article via Infotrieve]
12. Olsson MC, Patel JR, Fitzsimons DP, Walker JW, Moss RL. Basal myosin light chain phosphorylation is a determinant of Ca2+ sensitivity of force and activation dependence of the kinetics of myocardial force development. Am J Physiol. 2004; 287: H2712H2718.
13. Patel JR, Diffee GM, Huang XP, Moss RL. Phosphorylation of myosin regulatory light chain eliminates force-dependent changes in relaxation rates in skeletal muscle. Biophys J. 1998; 74: 360368.[Medline] [Order article via Infotrieve]
14. Levine RJC, Kensler RW, Yang Z, Stull JT, Sweeney HL. Myosin light chain phosphorylation affects the structure of rabbit skeletal muscle thick filaments. Biophys J. 1996; 71: 898907.[Medline] [Order article via Infotrieve]
15. Stelzer JE, Larsson L, Fitzsimons DP, Moss RL. Activation dependence of stretch activation in mouse skinned myocardium: implications for ventricular function. J Gen Physiol. 2006; 127: 95107.
16. Chen J, Kubalak SW, Minamisawa S, Price RL, Becker KD, Hickey R, Ross J, Chien KR. Selective requirement of myosin light chain 2v in embryonic heart function. J Biol Chem. 1998; 273: 12521256.
17. Holroyde MJ, Potter JD, Solaro RJ. The calcium binding properties of phosphorylated and unphosphorylated cardiac and skeletal myosins. J Biol Chem. 1979; 254: 64786482.
18. Flucher BE, Andrews SB. Characterization of spontaneous and action potential-induced calcium transients in developing myotubes in vivo. Cell Motil Cytoskel. 1993; 25: 143157.[CrossRef][Medline] [Order article via Infotrieve]
19. Li H, Cook JD, Terry M, Spitzer NC, Ferrari MB. Calcium transients regulate patterned actin assembly during myofibrillogenesis. Dev Dyn. 2004; 229: 231242.[CrossRef][Medline] [Order article via Infotrieve]
20. Xu X, Meiler SE, Zhong TP, Mohideen M, Crossley DA, Burggren WW, Fishman MC. Cardiomyopathy in zebrafish due to mutation in an alternatively spliced exon of titin. Nature Genetics. 2002; 30: 205209.[Medline] [Order article via Infotrieve]
21. Huang C, Sheikh F, Hollander M, Cai C, Becker D, Chu PH, Evans S, Chen J. Embryonic atrial function is essential for mouse embryogenesis, cardiac morphogenesis and angiogenesis. Development. 2003; 130: 61116119.
22. Aoki H, Sadoshima J, Izumo S. Myosin light chain kinase mediates sarcomere organization during cardiac hypertrophy in vitro. Nat Med. 2000; 6: 183188.[CrossRef][Medline] [Order article via Infotrieve]
23. Rayment I, Rypniewski WR, Schmidt-Base K, Smith R, Tomchick DR, Benning MM, Winkelmann DA, Wesenberg G, Holden HM. Three-dimensional structure of myosin subfragment-1: a molecular motor. Science. 1993; 261: 5058.
Related Article:
Circ. Res. 2006 99: 323-331.
This article has been cited by other articles:
![]() |
R. J. Solaro Multiplex Kinase Signaling Modifies Cardiac Function at the Level of Sarcomeric Proteins J. Biol. Chem., October 3, 2008; 283(40): 26829 - 26833. [Full Text] [PDF] |
||||
![]() |
J. Huang, J. M. Shelton, J. A. Richardson, K. E. Kamm, and J. T. Stull Myosin Regulatory Light Chain Phosphorylation Attenuates Cardiac Hypertrophy J. Biol. Chem., July 11, 2008; 283(28): 19748 - 19756. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Y. Chan, M. Takeda, L. E. Briggs, M. L. Graham, J. T. Lu, N. Horikoshi, E. O. Weinberg, H. Aoki, N. Sato, K. R. Chien, et al. Identification of Cardiac-Specific Myosin Light Chain Kinase Circ. Res., March 14, 2008; 102(5): 571 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ilancheran, A. Michalska, G. Peh, E. M Wallace, M. Pera, and U. Manuelpillai Stem Cells Derived from Human Fetal Membranes Display Multilineage Differentiation Potential Biol Reprod, September 1, 2007; 77(3): 577 - 588. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |